Floatz logo

Carboplatin

Peritoneal Carcinoma

CanariaBio Inc.Small moleculePhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Peritoneal Carcinoma cohort.

Asset / SponsorPhaseRating
STAPULDENCEL
SOTIO a.s.
Phase 3B
Eloxatin
University of Utah
Phase 2B
Interferon Gamma-1B
InterMune
Phase 3B
Gefetinib
Massachusetts General Hospital
Phase 2B
Arimidex
Massachusetts General Hospital
Phase 2B

View all 18 →

Same molecule, other indications

Carboplatin is also rated in:

lung large cell carcinomaDormant
A
Indicative ·
80 / 100
View asset →
non-small cell squamous lung carcinomaDormant
BBB
Indicative ·
76 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →